Who invested in ProQR Therapeutics?
ProQR Therapeutics's investors include Sofinnova Partners and Eli Lilly.

Netherlands · Funded startup
Funding summaryUpdated 26 Oct 2026
$68Mraised across 2 rounds since 2026, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From ProQR Therapeutics's own website: 6 on the team.
AdvisersThomas Wolf
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ProQR Therapeutics's investors include Sofinnova Partners and Eli Lilly.
ProQR Therapeutics has raised $68M across 2 rounds since 2026.
ProQR Therapeutics's most recent round was an Undisclosed round of $59M in Jun 2026.
Its most recent round, $59M in Jun 2026, is also its largest on record.
ProQR Therapeutics's first round on record, in Jan 2026, was backed by Sofinnova Partners and Eli Lilly.
ProQR Therapeutics's latest named round is an Undisclosed round, in Jun 2026.
ProQR Therapeutics is based in the Netherlands.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.